DDX15 Activators represent a unique chemical class of compounds, characterized by their ability to modulate the activity of the DDX15 protein, a member of the DEAD-box RNA helicase family. The primary role of DDX15 in cellular processes centers around its involvement in RNA metabolism, which includes RNA splicing, ribosome biogenesis, and possibly mRNA export. The modulation of DDX15 activity by activators can influence these RNA-related functions, showcasing the significance of this protein in maintaining cellular homeostasis.
The identification and characterization of DDX15 Activators have been driven by a combination of biochemical and molecular biology techniques. One key method involves the use of high-throughput screening (HTS) of chemical libraries to identify compounds that enhance DDX15 activity. This process entails monitoring the ATPase or helicase activity of DDX15 in the presence of various compounds. Such screenings can be executed using fluorescence-based assays, which offer a rapid and efficient means to assess the impact of a vast array of compounds on DDX15 function. Once potential activators are identified, further validation is conducted through in vitro assays, such as electrophoretic mobility shift assays (EMSAs) or helicase assays. These tests confirm the direct interaction between the activators and DDX15 and their effect on the enzyme's activity. Additionally, the structural elucidation of DDX15 Activators and their interaction with DDX15 is crucial for understanding their mechanism of action. Techniques like X-ray crystallography and NMR spectroscopy are employed to determine the molecular structure of these activators and their binding sites on DDX15.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA synthesis, potentially impacting the RNA metabolism processes involving DDX15. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Affects RNA processing and function, could indirectly impact DDX15's role in RNA metabolism. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Interferes with RNA and DNA synthesis, potentially affecting DDX15 activity. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA adducts, potentially impacting RNA transcription and processes involving DDX15. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, potentially affecting cellular processes and indirectly impacting DDX15. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, could affect transcription and indirectly influence DDX15. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially affecting DDX15's role in RNA metabolism. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, impacting nucleotide synthesis and potentially DDX15 activity. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Causes DNA breaks, potentially affecting transcription and DDX15's function. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
A nucleoside analog, can impact nucleotide metabolism and potentially affect DDX15. | ||||||